MedPath

The effect of l-carnitine and erythropoietin on anemia in hemodialysis patients

Phase 2
Conditions
Anemia.
Anemia in chronic kidney disease
D63.1
Registration Number
IRCT20200225046620N1
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Age of less than 30 years
Having a history of at least 6 month of dialysis

Exclusion Criteria

Having an active infectious or inflammatory disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Serum hemoglobin level. Timepoint: Before study, three month after taking drugs. Method of measurement: By measuring complete blood count in laboratory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath